Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]

Preemptively treating patients most at risk of progression to myeloma

Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain

Preemptively treating patients most at risk of progression to myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )

Drug combos with daratumumab likely to become standard of care in myeloma

Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland

Drug combos with daratumumab likely to become standard of care in myeloma ( Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland )

Overview of the CD38 antibody in multiple myeloma

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark

Overview of the CD38 antibody in multiple myeloma ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )

New drugs and combinations in haematological cancers improve complete remission...

Dr Paolo Corradini - University of Milan, Milan, Italy

New drugs and combinations in haematological cancers improve complete remission rates ( Dr Paolo Corradini - University of Milan, Milan, Italy )

Benefits and problems of allogeneic stem cell transplantation as multiple...

Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany

Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment ( Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany )

Innovative uses of kinase inhibitors in cancer

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Paediatric ALL with brain metastases

Dr Christina Halsey - University of Glasgow, Glasgow, UK

Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )

Can we reduce exposure to risk factors associated with childhood leukaemia and...

Dr Mark Miller - UCSF, San Francisco, USA

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers? ( Dr Mark Miller - UCSF, San Francisco, USA )

Genetic polymorphisms associated with childhood AML

Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil

Genetic polymorphisms associated with childhood AML ( Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil )

Childhood leukaemia and natural background radiation

Dr Gerald Kendall - University of Oxford, Oxford, UK

Childhood leukaemia and natural background radiation ( Dr Gerald Kendall - University of Oxford, Oxford, UK )

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Dr Daniel Lee - University of Virginia, Charlottesville, USA

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls ( Dr Daniel Lee - University of Virginia, Charlottesville, USA )

Development of a novel CD19 CAR with improved functionality

Anne Kramer - PhD student, University College London, London, UK

Development of a novel CD19 CAR with improved functionality ( Anne Kramer - PhD student, University College London, London, UK )

More from ecancer